Effect of Ticagrelor on four items of thrombi and platelet function in elderly patients with acute coronary syndrome after complex percutaneous coronary intervention
MO Xianwen1 SONG Renyi2 LIANG Leng1 LI Yanmei1 ZHU Jinyue1 QIN Yuanwen2 WU Chengjie2 QIN Ping1
1.Department of Medical Laboratory, Guidong People’s Hospital, Guangxi Zhuang Autonomous Region, Wuzhou 543001, China; 2.Department of Cardiovascular, Guidong People’s Hospital, Guangxi Zhuang Autonomous Region, Wuzhou 543001, China
Abstract：Objective To investigate the effect of Ticagrelor on four items of thrombi and platelet function in elderly patients with acute coronary syndrome (ACS) after complex percutaneous coronary intervention (PCI). Methods Sixty elderly patients with ACS treated by complex PCI in Guidong People’s Hospital, Guangxi Zhuang Autonomous Region, from January 2020 to December 2021 were selected for this study, and the patients were divided into control group (30 cases) and study group (30 cases) by random number table method. The patients were treated with conventional medication after complicated PCI, including the control group treating by Clopidogrel combined with Aspirin and the study group treating by Ticagrelor combined with Aspirin, and the duration of treatment in both groups was six months. The four items of thrombi and platelet function were compared between the two groups before medication and one month after medication, and the occurrence of adverse cardiovascular events in the two groups during six months after complex PCI was recorded. Results One month after medication, the levels of thrombin-antithrombin, thrombomodulin, tissue-type plasminogen activator- plasminogen activator inhibitor 1 complex, and plasmin- α2-plasmin inhibitor complex in the two groups were lower than those before medication, and those in the study group were lower than those in the control group (P＜0.05). One month after medication, the arachidonic acid inhibition rate, adenosine diphosphate inhibition rate, adenosine diphosphate induced fibrin clot intensity, and platelet reactivity index in the two groups were higher than those before medication, and those in the study group were higher than those in the control group (P＜0.05). Within six months of treatment, the total incidence of cardiovascular adverse events in the study group was lower than that in the control group (P＜0.05). Conclusion Ticagrelor combined with Aspirin has good anti-platelet effect in elderly ACS patients after complex PCI, which can improve platelet function and reduce the incidence of adverse cardiovascular events.
莫显文1 宋仁义2 梁棱1 李炎梅1 朱金月1 覃远文2 吴承杰2 覃平1. 替格瑞洛对急性冠状动脉综合征复杂经皮冠脉介入术后老年患者血栓四项及血小板功能的影响[J]. 中国医药导报, 2023, 20(29): 70-73,82.
MO Xianwen1 SONG Renyi2 LIANG Leng1 LI Yanmei1 ZHU Jinyue1 QIN Yuanwen2 WU Chengjie2 QIN Ping1. Effect of Ticagrelor on four items of thrombi and platelet function in elderly patients with acute coronary syndrome after complex percutaneous coronary intervention. 中国医药导报, 2023, 20(29): 70-73,82.
2023, Vol. 20 
京公网安备 11010502046598号